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Background: Menopausal symptoms are associated with inflammation. Curcumin is a well-known anti-
inflammatory bioactive compound from turmeric whereas tetrahydrocurcumin (THC) is a major metabolite of
curcumin that may have different efficacies. However, they have not been studied for anti-menopausal symptoms
and anti-osteoarthritis effects. We compared the efficacies of curcumin and THC for preventing postmenopausal
and osteoarthritis symptoms in ovariectomized (OVX) obese rats with monoiodoacetate (MIA) injections into the
right knee to generate a similar pathology as osteoarthritis.
Methods: OVX rats were provided a 45 % fat diet containing either (1) 0.4 % curcumin (curcumin), (2) 0.4 % THC,
(3) 30 μg/kg body weight 17β-estradiol + 0.4 % dextrin (positive control), (4) 0.4 % dextrin (placebo; control), or (5)
0.4 % dextrin with no MIA injection (normal control) for 4 weeks. At the beginning of the fifth week, OVX rats were
given articular injections of MIA or normal-control saline into the right knee and the assigned diets were provided
for an additional 3 weeks.
Results: Curcumin and THC had similar efficacies for skin tail temperature in OVX rats whereas THC, but not
curcumin, prevented glucose intolerance, which might be involved in exacerbating osteoarthritis. Both protected
against osteoarthritis symptoms and pain-related behaviors better than 17β-estradiol treatment in estrogen-
deficient rats. Curcumin and THC prevented the deterioration of articular cartilage compared to control. They also
maintained lean body mass and lowered fat mass as much as 17β-estradiol treatment. The improvement in
osteoarthritis symptoms was associated with decreased gene expressions of matrix metalloproteinase (MMP)3 and
MMP13 and tumor necrosis factor-α, interleukin (IL)1β, and IL6 in the articular cartilage.
Conclusions: THC and curcumin are effective for treating postmenopausal and osteoarthritis symptoms in OVX rats
with MIA-induced osteoarthritis-like symptoms and may have potential as interventions for menopausal and
osteoarthritic symptoms in humans.
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Fig. 1 Chemical structure of curcumin and tetrahydrocurcumin. a
Curcumin, C21H20O6. b Tetrahydrocurcumin, C21H24O6
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Osteoarthritis (OA) is a degenerative joint disease that is
characterized by a slow deterioration of the joints. OA is
a leading cause of physical disability, and its incidence is
rising due to increasing obesity and an aging population
(Johnson and Hunter 2014). Both are associated with
systemic inflammation (Greene and Loeser 2015). The
prevalence of knee OA increased 26.6 % from 1990 to
2010 in 21 epidemiological regions worldwide (Vos et al.
2012). The occurrence of OA increases with age due to
the decreased capacity to suppress inflammation, age-
related sarcopenia, and increased bone turnover
(Johnson and Hunter 2014). Women experience a higher
prevalence and severity of OA in the hands, feet, and
knees than men and are more often affected with OA
than men (Srikanth et al. 2005). In women, the risk of
OA especially increases at menopause and estrogen pro-
tects against OA (Hanna et al. 2004). The gender dispar-
ities in OA may be related to multiple factors including
the following: pain sensitivity, lower volume of knee car-
tilage, bone strength, alignment, ligament laxity, preg-
nancy, and neuromuscular strength (Johnson and
Hunter 2014). In addition, the dysregulation of glucose
and energy metabolism also exacerbates OA symptoms
in postmenopausal women (King and Rosenthal 2015;
Thijssen et al. 2015). Therefore, postmenopausal women
are clearly more susceptible to OA.
There is no effective treatment for OA. Since the exact
causes of the disease remain unknown, fundamental
drugs have not been developed. OA is induced by the in-
flammation and catabolism of the joints, which causes
severe pain (Houard et al. 2013; Wu et al. 2012). The
current OA treatments mostly address joint pain. The
existing pharmaceuticals for OA such as analgesics, ste-
roids, and non-steroidal anti-inflammatory drugs reduce
the symptoms of OA by reducing pain and inflammation
(Suokas et al. 2014). However, their long-term use can-
not be sustained due to inadequate pain relief or serious
gastrointestinal and cardiovascular adverse events
(Schnitzer 2006). Therefore, new treatments for OA with
better safety and efficacy are needed.
Curcumin is an active component of turmeric (Cur-
cuma longa), which has a long history of safe use in
foods. It has long been used as an anti-inflammatory
treatment in traditional Chinese and Ayurvedic medicine
(Goel et al. 2008). The yellow-pigmented fraction of tur-
meric contains curcuminoids, which are chemically re-
lated to its principal ingredient, curcumin. Curcumin is
reported to have beneficial effects on OA, type 2
diabetes, and dyslipidemia. Turmeric extracts change
colors according to acidic and alkaline pH, and tetrahy-
drocurcumin (THC), a major metabolite of curcumin,
is whitish colored. THC has also been reported to
have anti-oxidant, anti-inflammatory, chemopreventive,anti-bacterial, anti-dyslipidemic, and anti-aging activities
(Muthumani and Miltonprabu 2015; Sangartit et al.
2014; Wu et al. 2014; Xiang et al. 2011). Although THC
has similar effects, recent studies have shown that THC
has superior anti-oxidant properties with increased GSH
peroxidase, glutathione-S-transferase, NADPH: quinine
reductase, and free radical quenching activities (Aggarwal
et al. 2015). In addition, curcumin is stable at pH 1–6
(Wang et al. 1997) but not at neutral pH (about pH 7–8)
and loses anti-oxidant capacity. Thus, curcumin may be
degraded in the intestines and may not work as an anti-
oxidant in vivo. Curcumin which is not degraded in the
intestines is metabolized into THC that is quite stable and
still possesses anti-oxidant activities at neutral or basic pH
(Murugan and Pari 2006) (Somparn et al. 2007). Thus,
THC may be more potent in the intestines than curcumin
in animals and humans.
The hypothesis of the present study was that the long-
term consumption of tetrahydrocurcumin and curcumin
would prevent and delay the symptoms of OA in obese
animals with estrogen deficiency. The present study
tested the hypothesis and explored the nature of their
protection against OA in ovariectomized (OVX) rats
with OA induced by intra-articular injection of monoio-
doacetate (MIA). The MIA injection is known to
produce a similar pathology as OA by disrupting gly-
colysis at the site of the injection resulting in the
eventual death of chondrocytes and by increased inflam-
mation (Guzman et al. 2003).Methods
The major components
The curcumin extract contained curcumin, demethoxy-
curcumin, and bismethoxycurcumin at 79.9, 17.0, and
3.1 %, respectively, and the purity of THC was 95.7 %.
As determined by HPLC (Sami Labs Limited, Bangalore,
India). THC from C. longa were generously provided by
Sabinsa Corp. (NJ, USA). Their chemical structures are
given in Fig. 1.
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The dosages of curcumin and tetrahydrocurcumin were
determined by our preliminary study: each test diet
contained 0.4 % curcumin or tetrahydrocurcumin in a
high-fat diet. The dosage in the diet was based on our
preliminary cell culture study: low dosage (0.5–1.5 μg/mL)
treatment of curcumin and tetrahydrocurcumin lowered
tumor necrosis factor-α (TNF-α) expression in lipopoly-
saccharide (LPS) activated RAW 264.7 cells (mouse leu-
kaemic monocyte/macrophage cell line).
All groups had high-fat diets that were intended to ex-
acerbate the progression of OA and menopausal symp-
toms, possibly due to obesity, as compared to a low-fat
diet (Lizcano and Guzman 2014; Thijssen et al. 2015).
The semi-purified modified AIN-93 diet (Reeves 1997)
consisted of 35 % energy (En%) from carbohydrates, 20
En% from protein, and 45 En% from fats. The major
carbohydrate, protein, and fat sources were starch plus
sugar, casein (milk protein), and lard (CJ Co., Seoul,
Korea), respectively. High-fat diets were supplemented
with 0.4 % curcumin, tetrahydrocurcumin, or dextrin
(control) or 30 μg/kg body weight 17β-estradiol + 0.4 %
dextrin (positive control) to make the nutrient compos-
ition of the diets the same. Each powder of curcumin
and tetrahydrocurcumin was homogeneously mixed with
the vitamin and mineral mixture and sugar, and then,
the mixture was sifted to break apart lumps. Each mix-
ture was blended with the appropriate amounts of
starch, casein, and lard; sifted again; and stored at 4 °C.
Every other day, the remaining feed was removed and
weighed to measure consumption, and fresh weighed
feed was provided. The amount of each supplement con-
sumed (dosage) was calculated from the feed intake.
Estrogen-deficient and MIA-induced OA animal model
Female Sprague Dawley rats (weighing 231 ± 20 g) were
housed individually in stainless steel cages in a con-
trolled environment (23 °C and with a 12-h light/dark
cycle). This research followed the guidelines of the NIH
Guide for the Care and Use of Laboratory Animals and
the International Association for the Study of Pain and
was approved by the Animal Care and Use Committee
of Hoseo University, Korea (2013-04). After purchasing
Sprague Dawley rats from DBL (Yeumsung-Kun, Korea),
they were acclimated for 1 week in our animal facility.
Rats underwent ovariectomy (OVX) under anesthesia in-
duced by subcutaneous injection of a mixture of keta-
mine and xylazine (100 and 10 mg/kg body weight,
respectively, used for all anesthesia) (Ko et al. 2014). A
mid-ventral incision was made, and each ovary was iso-
lated by ligation of the most proximal portion of the ovi-
duct, and then, ovaries were removed with scissors.
After a 4-week treatment with the assigned diets, each
OVX rat was then subjected to a single intra-articularinjection of MIA (4 mg/50 μL saline; Sigma Co.) through
the patellar ligament of the right knee, using a 26-gauge
needle after anesthetization (Park et al. 2014). The
normal-control group had a single intra-articular injec-
tion of saline into the right knee of the OVX rats fed a
high-fat diet. On the day following MIA injections, the
rats were carefully observed for their posture, behaviors,
and development of swelling in the right knee by a
trained technician who evaluated all rats.
Experimental design
The OVX rats were randomly assigned to the follow-
ing five groups (n = 10 each): (1) MIA injection into
the knee and 0.4 % curcumin (curcumin), (2) MIA in-
jection into the knee and 0.4 % tetrahydrocurcumin
(THC), (3) MINA injection into the knee and 30 μg/
kg body weight 17β-estradiol + 0.4 % dextrin (positive
control), (4) MIA injection into the knee and 0.4 %
dextrin (placebo; control), and (5) saline injection into
the knee and 0.4 % dextrin (normal control). After
OVX operations, the rats were given free access to
water and their respective diets.
After 4 weeks of providing the assigned diets, MIA or
saline was injected into the right knee of the OVX rats
of each group as described below and the assigned diets
were provided for an additional 3 weeks. At the seventh
week of the experimental period, an oral glucose toler-
ance test (OGTT) was performed in overnight feed-
deprived rats by orally administering 2 g/kg body weight
of glucose every 10 min for 90 and 120 min and serum
insulin levels were measured at 0, 20, 40, 60, 90, and
120 min (Ko et al. 2014). Serum glucose and insulin
levels were measured using a glucometer (Accuchek,
Roche Diagnostics, Indianapolis, IN) and RIA kit (Linco
Research, Billerica, MA), respectively. Insulin resistance
was determined using the homeostasis model assessment
estimate of insulin resistance (HOMA-IR) calculated
using the following equation: HOMA-IR = fasting insulin
(μIU/ml) × fasting glucose (mM)/22.5. At the end of the
study, the rats were anesthetized and peri-uterine and
retroperitoneal fat pads and uteri were removed and
weighed. Blood samples for serum isolation were col-
lected by cardiac puncture, allowed to coagulate, and
serum prepared by centrifugation and then stored at
−70 °C for biochemical analysis.
Tail skin temperature measurement
Tail skin temperature was monitored on the fourth
and eighth weeks of the experimental periods during
the sleep cycle using an infrared thermometer (BIO-
152-IRB, Bioseb, Chaville, France) designed for small
rodents. Three measurements were made 10 min
apart, and the average value for the animal was used
as a single data point.
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Prior to use, a dual-energy X-ray absorptiometer (DEXA;
Norland pDEXA Sabre; Norland Medical Systems Inc.,
Fort Atkinson, WI, USA) was calibrated with a phantom
supplied by the manufacturer. After anesthetization, the
animals were laid in a prone position, with the posterior
legs maintained in external rotation with tape. The hip,
knee, and ankle articulations were in 90° flexion. Upon
the completion of scanning, bone mineral density
(BMD) was determined in the right femur and knee
using the DEXA instrument equipped with the appropri-
ate software for assessment of bone density in small ani-
mals (Ko et al. 2014). Similarly, abdominal fat mass and
lean mass were measured by DEXA.
Progression of OA and pain-related behavior tests
At 3, 7, 14, and 21 days after MIA injection, the diame-
ters of the knees were measured every week using digital
calipers (Mitotoyo, Japan). For gross observation, all ex-
perimental rats were weighed and carefully inspected
every week to assess knee joint swelling and gait distur-
bances under natural conditions in the cages, where they
were allowed to move freely. Swelling and limping were
classified as no change (0), mild (1), moderate (2), and
severe (3) on the basis of severity (Kobayashi et al.
2003). All assessments were conducted by the same
trained inspector who was blinded to treatment details
throughout the study period.
At 7, 14, and 21 days after MIA injection, pain-related
behaviors were assessed by an incapacitance test using a
hind paw limb weight-bearing apparatus (Linton Incapa-
citance Tester, UK) and the maximum running speed on
a treadmill. These tests have been utilized as indices of
joint discomfort and may be useful for the discovery of
novel pharmacologic agents in human OA (Pomonis
et al. 2005). The incapacitance tester is a device that
compares differences in hind paw weight distribution be-
tween the right (osteoarthritic) and left (control) limbs.
Animals were acclimated for 30 min before the test.
Measurements were performed five times in each rat,
and the average of the middle three values was calcu-
lated. Percent weight distribution of the right hind paw
was calculated using the following formula: % weight
distribution of right hind paw = right weight/(left weight
+ right weight) × 100 (Bar-Yehuda et al. 2009). Since ani-
mals with OA cannot walk or run as fast as normal ani-
mals, the maximum running speed can be a diagnostic
criterion for OA. Rats were acclimated to the treadmill
at 40 cm/s for 1 min and then increased to 50 cm/s for
1 min. Subsequently, the speed of the treadmill was in-
creased by 5 cm/s at 1 min intervals until the rats could
not continue running and slid into the back of the tread-
mill. The maximum speed for running by rats was de-
fined as the fastest speed the rats could maintain for20 s. All experimental rats were subjected to the tread-
mill test for less than 5 min in each experiment.
Isolation of total RNA from articular cartilage and
real-time PCR
Articular cartilage samples from five rats of each group
were collected 28 days after MIA injection, and each car-
tilage was individually powdered with a cold steel mortar
and pestle and then mixed with a monophasic solution of
phenol and guanidine isothiocyanate (TRIzol reagent, Life
Technologies, Rockville, MD, USA) for total RNA extrac-
tion, following the manufacturer’s instructions. RNA con-
centrations were determined using a Lamda 850
spectrophotometer (Perkin Elmer, Waltham, MA, USA).
The cDNA was synthesized from 1 μg total RNA ex-
tracted from each rat using a superscript III reverse tran-
scriptase kit (Life Science Technology). Five different
cDNA transcripts were made from five rats from each
group and were used for real-time PCR. The cDNA from
each rat and primers for specific genes were mixed with
SYBR Green mix (Bio-Rad, Richmond, CA) in duplicate
and amplified using a real-time PCR instrument (Bio-
Rad). Thermal cycling conditions were 55 °C for 2 min,
95 °C for 10 min followed by 40 cycles of 94 °C for 20 s,
65 °C for 30 s, and 72 °C for 20 s. To assess genes associ-
ated with the inflammation and degradation of articular
cartilage, primers of TNF-α, interleukin (IL)1β, IL6, matrix
metalloproteinase (MMP)3, and MMP13 genes were used
as described previously (Ko et al. 2014; Park et al. 2014).
The gene expression levels in unknown samples were
quantitated using the comparative cycle of threshold (CT)
method (ΔΔCT method) (Livak and Schmittgen 2001).
ΔCT was calculated using the formula: ΔCT =CT (target
gene) −CT (endogenous reference gene, β-actin). The
relative fold-change in expression was calculated by the
equation of ΔΔCt =ΔCttreatment −ΔCtcontrol. Results were
presented as 2−ΔΔCT.
Histopathological analysis of knee
After 21 days following MIA injection, rats were sacri-
ficed and histologically examined to assess chronic mor-
phological changes in the knee articular bones for
narrowing, loss of joint region, cartilage erosion, and
osteophyte formation (Bar-Yehuda et al. 2009; Guzman
et al. 2003; Park et al. 2014). For histological analysis,
knee joints were removed, fixed in phosphate-buffered
formalin, decalcified in 10 % nitric acid for 72 h, and
embedded in paraffin. Five-micrometer sections were
stained with hematoxylin and eosin (H-E) and safranin-
O fast green, and morphological changes were observed.
Histopathological changes in each animal were quantita-
tively expressed by the following scoring system
(Guzman et al. 2003). Cartilage damage was evaluated
according to the depth and extent of the damage on a
Fig. 2 Tail skin temperature at the third and seventh weeks of the
experimental periods. Ovariectomized (OVX) rats were provided with
a 45 % fat diet containing (1) 0.4 % curcumin, (2) 0.4 %
tetrahydrocurcumin (THC), (3) 30 μg/kg body weight 17β-estradiol
+ 0.4 % dextrin (positive control), (4) 0.4 % dextrin (control), or (5)
0.4 % dextrin (normal control for osteoarthritis). At the beginning of
the fifth week, an articular injection of monoiodoacetate into the
right knee was performed on all OVX groups except the normal-
control group and the assigned diets were provided for an
additional 3 weeks. Rats in the normal-control group had articular
injections of saline in the right knee. Tail skin temperature was
measured at the fourth and seventh weeks. Each bar represents
mean ± SD (n = 10). (a, b) The bars with different letters were
significantly different among groups by the Tukey test at P < 0.05
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the superficial zone only; 2, mild invasion into the upper
middle zone; 3, moderate invasion well into the middle
zone; 4, marked invasion into the deep zone but not to
the tidemark; and 5, severe full-thickness degradation to
the tidemark. The extent of tibial plateau involvement
and proteoglycan loss were scored as 1 (minimal), 2
(mild), 3 (moderate), and 4 (severe).
Statistical analysis
Statistical analysis was performed using SAS software
version 7 (SAS Institute, Cary, NC), and all results are
expressed as a means ± SD. The variables that were
measured at different time points were analyzed with
two-way repeated measures ANOVA with time and
group as independent variables and interaction term be-
tween time and group. One-way ANOVA was used to
assess the metabolic effects of control, curcumin, THC,
17β-estradiol (a positive control), and normal controls
(rats with saline injection) at a single time point at the
end of the experiment. Significant differences in the
main effects among the groups were identified by
Tukey’s test at P < 0.05.
Results
Curcumin and tetrahydrocurcumin suppress menopausal
symptoms
Tail skin temperature after OVX, representing hot flush
in menopausal women, increased over the first 3 weeks
in all groups. At the third week, there were few differ-
ences in tail temperatures among the groups, with only
the positive control having a slightly lower temperature.
However, by the seventh week, the curcumin, THC, and
positive-control groups all had significantly lower tem-
peratures than the control and normal-control groups
(Fig. 2).
OVX rats had higher body weights than positive-
control rats at the fourth and seventh weeks, but food
intake was not significantly different. Curcumin and
THC consumption did not change the increase of body
weight in OVX rats, and food intake was not signifi-
cantly different (Table 1). The average intake of curcu-
min and THC, as calculated from feed consumption,
was about 55–57 mg/day/rat, which corresponds to
about 900–1500 mg of each for humans. Peri-uterine
and retroperitoneal fat pad weights were greater in con-
trol rats than positive-control rats, and unlike body
weight, curcumin and THC lowered their fat mass
(Table 1). Interestingly, THC decreased the retroperiton-
eal fat mass more than curcumin. OVX rats had lower
uterine weight and serum 17β-estradiol levels, and they
were both normalized by 17β-estradiol treatment, but
not by curcumin and THC (Table 1). Thus, the modula-
tion of fat mass by curcumin and THC is not due toincreased secretion of 17β-estradiol. Serum triglyceride
levels also increased in control rats in comparison to the
positive-control rats and curcumin, and THC prevented
the increase as much as in the positive-control rats.
Glucose metabolism
Control and normal-control rats both had mildly im-
paired glucose intolerance due to the high-fat diets, as
evidenced by HOMA-IR which is a reliable predictor of
insulin resistance in rats (Cacho et al. 2008). Overnight-
fasted serum glucose levels were higher in both OVX
and normal-control groups than in positive-control rats
which also had lower serum insulin concentrations
(Table 1), indicating increased insulin sensitivity in
positive-control rats, which was confirmed by HOMA-
IR. Curcumin and THC also increased insulin concen-
trations and sensitivity, but not quite as much as in
positive controls.
After the oral glucose challenge, serum glucose levels
were elevated up to 40–50 min and then they slowly de-
creased in all rats (Fig. 3a). Control rats had higher
peaks at 50 min than the positive-control rats whereas
curcumin and THC treatment tended to lower it below
that of the normal-control group. Area under the curve
(AUC) of glucose in the first and second part of the
OGTT was higher in controls than the positive controls,
and AUC of glucose was similar in the THC group to
the positive control (Fig. 3b). AUC of insulin in the first
and second part of the OGTT was much higher in control
Table 1 Metabolic parameters at the end of experimental periods
Control (n = 10) Curcumin (n = 10) THC (n = 10) Positive control (n = 10) Normal control (n = 10)
Body weight at fourth week (g) 347 ± 32a 332 ± 30a 337 ± 29a 301 ± 22b 346 ± 31a
Body weight at seventh week (g) 332 ± 34b 328 ± 33b 329 ± 35b 297 ± 26c 367 ± 36a
Food intake at fourth week (g) 14.8 ± 1.7 14.0 ± 1.5 13.6 ± 2.0 13.1 ± 1.4 14.7 ± 1.8
Food intake at seventh week (g) 13.3 ± 1.6b 14.3 ± 1.9ab 14.0 ± 1.8ab 13.1 ± 1.7b 15.4 ± 1.7a
Average intake of supplements (mg/day) – 57.4 ± 6.5 55.6 ± 6.1 – –
Peri-uterine fat (g) 7.9 ± 1.1a 6.1 ± 0.7b 6.7 ± 0.8b 4.9 ± 0.9c 8.4 ± 0.9a
Retroperitoneum fat (g) 11.7 ± 2.0a 9.9 ± 1.1b 7.4 ± 1.0c 5.8 ± 0.5d 12.3 ± 1.8a
Uterine weight (g) 0.17 ± 0.06b 0.22 ± 0.07b 0.20 ± 0.05b 0.51 ± 0.08a 0.18 ± 0.05b
Serum 17β-estradiol levels (pg/ml) 1.6 ± 0.6b 1.8 ± 0.5b 1.9 ± 0.5b 7.5 ± 1.1a 1.7 ± 0.6b
Serum triglyceride (mg/dL) 85.9 ± 5.3a 71.9 ± 6.4b 70.4 ± 7.4b 68.3 ± 6.6b 84.3 ± 5.5a
Serum glucose (mg/dL) 103 ± 8a 98 ± 7a 100 ± 8a 88 ± 10b 102 ± 7a
Serum insulin (ng/mL) 1.49 ± 0.17a 1.21 ± 0.14b 1.26 ± 0.17b 1.19 ± 0.11b 1.43 ± 0.15a
HOMA-IR 8.5 ± 0.9a 6.6 ± 0.8b 6.9 ± 0.9b 5.8 ± 0.6c 8.1 ± 0.8a
Ovariectomized (OVX) rats were provided with a 45 % fat diet containing (1) 0.4 % curcumin, (2) 0.4 % tetrahydrocurcumin (THC), (3) 30 μg/kg body weight
17β-estradiol + 0.4 % dextrose (positive control), (4) 0.4 % dextrose (control), or (5) 0.4 % dextrose (normal control for osteoarthritis). At the beginning of the fifth
week, an articular injection of monoiodoacetate into the right knee was performed on all OVX groups except the normal-control group and the assigned diets
were provided for additional 3 weeks. Rats in the normal-control group had an articular injection of saline in the right knee. Values are mean ± SD
a, b, cValues on the same row with different superscripts were significantly different among groups by the Tukey test at P < 0.05
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THC groups had AUC of insulin similar to the positive
control (Fig. 3c). Therefore positive-control, curcumin-,
and THC-treated rats had greater insulin sensitivities than
either the normal-control or control rats.Global observations and pain-related behaviors of OA
symptoms
MIA, but not saline, injection induced global OA symp-
toms such as limping and swelling. After MIA injection,
the global symptoms were scored weekly. Swelling was
greater in the control group than the other groups, and
it gradually decreased as time passed. Curcumin and
THC markedly reduced swelling to levels near the nor-
mal controls by the seventh week, but it was not quite
normal (Fig. 4a). In positive controls, swelling was less
than in the control but not as low as with curcumin and
THC. The limping score showed a similar trend of swell-
ing (Fig. 4b).
OA is accompanied with pain, the severity of which
was mainly determined by the maximum velocity of run-
ning on a treadmill and asymmetric weight distribution.
Running at maximum velocity was slower in the control
group, and it increased as time passed, but the increase
was small. Rats in the curcumin, THC and positive-
control groups had similar maximum running velocities
as those in the normal-control group (Fig. 4c). In
addition, weight distribution in the right knee was much
less than in the left knee since the right knee had pain in
all MIA-treated rats during the first week after MIA in-
jection. It was ameliorated better in the curcumin- andTHC-treated rats than in the control rats as time passed
(Fig. 4d).
Body composition in the hip and right leg
After 4 weeks of OVX, BMD of the hip and right leg
began to be lower in control rats than positive-control
rats and continued to decrease through week 7 (Fig. 5a).
Curcumin and THC did not prevent the loss of BMD in
comparison to the control group. Lean body mass was
lower in control rats than positive-control rats in weeks
4 and 7, but unlike BMD, the loss was reversed and it
was partially restored by week 7. Curcumin exhibited a
tendency to increase lean body mass in the hips and
legs, but it was significantly different from other groups
only in the right leg at 4 weeks (Fig. 5b). THC increased
the lean body mass in the hip and leg to as much as the
positive control. The increase in lean body mass was also
associated with decreased fat mass. Control rats had
much greater fat mass in the hip and right leg than
positive-control rats (Fig. 5c). Fat mass was much
greater in the control rats than in the positive-control
rats in the fourth and seventh week, and curcumin and
THC prevented the increase in comparison to the con-
trol rats. At the seventh week, the decrease in the hip
and leg was not as much as in the positive-control rats.
The mRNA expressions of cytokines in the articular
cartilage of the right knee
MIA is known to initiate OA by activating matrix metal-
loproteinases and by inducing inflammation and elevat-
ing cytokine release. MMPs are collagenases that break
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Fig. 3 The area under the curve of serum glucose and insulin during oral glucose tolerance test (a–c). Ovariectomized (OVX) rats were provided
with a 45 % fat diet containing (1) 0.4 % curcumin, (2) 0.4 % tetrahydrocurcumin (THC), (3) 30 μg/kg body weight 17β-estradiol + 0.4 % dextrin
(positive control), (4) 0.4 % dextrin (control), or (5) 0.4 % dextrin (normal control for osteoarthritis). At the beginning of the fifth week, an articular
injection of monoiodoacetate into the right knee was performed in all OVX groups except the normal-control group. Rats in the normal-control
group had articular injections of saline in the right knee. At 2 weeks after injecting MIA, oral glucose tolerance tests were performed with 2 g
glucose per kilogram body weight. Blood samples were taken at the time points indicated, glucose and serum were measured, and the area
under the curve of glucose and insulin was calculated. The dots or bars and error bars represent mean ± SD (n = 10). Asterisks represent the
significant treatment effect by repeated measures of a two-way ANOVA test at P < 0.05. (a, b) The bars or dots with different letters were significantly
different among groups by the Tukey test at P < 0.05
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in more control rats than in normal-control rats, but
curcumin and THC suppressed their expressions com-
pared to the control group. THC decreased their expres-
sion slightly better than curcumin, but it was not
significantly different whereas the positive-control group
did not decrease as much as the THC (Fig. 6a).
MIA increased the expression of pro-inflammatory cy-
tokines such as TNF-α, IL1β, and IL6 in the articular
cartilage of control rats in comparison to the normal-
control rats. Curcumin and THC prevented the increase
in the pro-inflammatory cytokine expressions in com-
parison to the control group, and estradiol treatment
also decreased their expression (Fig. 6b). Curcumin low-
ered TNF-α expression more than the 17β-estradiol
treatment of the positive controls.
Histopathological analysis
Histological evaluations using H-E staining revealed that
MIA injection resulted in damage to the articularcartilage and subchondrial bone of the knee in control
rats (Fig. 7a). The normal-control rats exhibited normal
articular cartilage structures having smooth articular
surfaces, normal chondrocytes with columnar orienta-
tion, and intact tidemark and subchondrial bone. How-
ever, MIA injection into the knee of OVX rats induced
the degeneration of columnar orientation, degeneration
of tidemark, and penetration of subchondrial bones, and
estrogen deficiency exacerbated the histological scores of
the knees injected with MIA (Fig. 7a). In the descending
order of 17β-estradiol treatment, curcumin, and THC, the
articular structure degeneration was lessened in MIA-
injected knees, which reduced the penetration of subchon-
drial bones, but did not protect against the degeneration of
tidemarks (Fig. 7a). Safranin-O fast green staining revealed
that proteoglycan loss was increased in control rats whereas
the articular cartilage loss was significantly reduced in the
descending order of positive-control, curcumin, and THC
treatments (Fig. 7b). Curcumin and THC did not improve
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Fig. 4 Gross observation of osteoarthritis symptoms and pain-related behaviors at 3, 7, 14, and 21 days after monoiodoacetate (MIA) injection.
Ovariectomized (OVX) rats were provided with a 45 % fat diet containing (1) 0.4 % curcumin, (2) 0.4 % tetrahydrocurcumin (THC), (3) 30 μg/kg
body weight 17β-estradiol + 0.4 % dextrin (positive control), (4) 0.4 % dextrin (control), or (5) 0.4 % dextrin (normal control for osteoarthritis). At
the beginning of the fifth week, an articular injection of monoiodoacetate into the right knee was performed on all OVX groups except the
normal-control group and the assigned diets were provided for an additional 3 weeks. Rats in the normal-control group had an articular injection
of saline in the right knee. In a gross observation of osteoarthritis symptoms, the scores of the swelling (a) and limping (b) in the right knee were
measured. As indicators of knee pain, differences in weight distribution of the right hind paw (c) were measured by an incapacitance tester and
maximum running velocity on a treadmill (d) was determined. Each data point and error bar represents the mean ± SD (n = 10). Asterisks represent
the significant treatment effect by repeated measures of a two-way ANOVA test at P < 0.05. (a, b, c, d) The dots with different letters were significantly
different among groups in the Tukey test at P < 0.05
Park et al. Genes & Nutrition  (2016) 11:2 Page 8 of 13morphologies as the normal control (Fig. 7b). These results
indicate that curcumin and THC treatment prevented the
breakdown of the articular surface in OVX rats with the
MIA injection into the right knee. THC had a better effi-
cacy in the changes of knee morphology than curcumin in
OVX rats injected with MIA.
Discussion
The present study compared the efficacies of curcumin
and THC for preventing postmenopausal and OA symp-
toms in OVX rats with MIA injection into the right
knee. Curcumin and its food source, turmeric, have long
histories as both food and medicines. THC is one of the
metabolites of curcumin. Curcumin and THC had simi-
lar efficacies for skin tail temperature in OVX rats,whereas THC, but not curcumin, prevented impairment
of glucose tolerance. Both protected against OA symp-
toms and pain-related behaviors better than 17β-estradiol
treatment in estrogen-deficient rats. They also maintained
lean body mass and lowered fat mass as much as 17β-
estradiol treatment. The improvements in OA symptoms
were associated with decreased expressions of MMPs and
pro-inflammatory cytokines. Therefore, curcumin and
THC have similar efficacies for OA symptoms and are po-
tential interventions for human osteoarthritis.
As life expectancy increases, the prevalence of OA is
elevated, and women have about a twofold higher inci-
dence than men and it is markedly increased in post-
menopausal women. There are also many modifiable
risk factors for OA including the following: obesity,
Fig. 5 Bone mineral density (BMD) and lean mass of the femur and knee with intra-articular injection of monoiodoacetate (MIA) at days 0 and 21
after MIA injection. Ovariectomized (OVX) rats were provided with a 45 % fat diet containing (1) 0.4 % curcumin, (2) 0.4 % tetrahydrocurcumin
(THC), (3) 30 μg/kg body weight 17β-estradiol + 0.4 % dextrin (positive control), (4) 0.4 % dextrin (control), or (5) 0.4 % dextrin (normal control for
osteoarthritis). At the beginning of the fifth week, an articular injection of monoiodoacetate into the right knee was performed on all OVX groups
except the normal-control group and the assigned diets were provided for an additional 3 weeks. Rats in the normal-control group had an
articular injection of saline in the right knee. BMD (a) and lean body mass (b) of the hip and right leg and fat mass of the abdomen and right leg
(c) were measured by DEXA. Each bar and error bar represents the mean ± SD (n = 10). (a, b, c) The bars with different letters were significantly
different among groups by Tukey test at P < 0.05
Park et al. Genes & Nutrition  (2016) 11:2 Page 9 of 13high-fat diets, physical activity, muscle strength, joint
alignment, and bone metabolism (Johnson and Hunter
2014). Thus, the animal model selected for the present
study was an estrogen-deficient OVX rat with MIA
injected into the knee and fed a high-fat diet. In the
present study, we investigated whether curcumin and
THC prevented the exacerbation of OA symptoms in
OVX rats injected with MIA into the knee and fed a high-
fat diet. This animal model was proper for investigating
the changes of OA symptoms by herbal treatment.
Although the cause of OA is not known, OA is related
to the loss of articular cartilage due to inflammation and
protein degradation enzymes. OA treatment focuses on
relieving pain, improving joint mobility, increasing the
strength of the joints, and minimizing the disabling ef-
fects of the disease (Aggarwal et al. 2015). The drugs
commercially used have adverse effects, and alternative
treatments have been investigated. Curcumin is a highly
pleiotropic molecule with a strong safety record. Con-
vincing molecular evidence supports its efficacy for
targeting multiple inflammatory diseases including
OA. Curcumin has been reported to reduce inflamma-
tion in OA in cell-based studies and animal and hu-
man studies (Colitti et al. 2012; Henrotin et al. 2010;
Panahi et al. 2015; Panahi et al. 2014; Shakibaei et al.2011; Yeh et al. 2015). Most of these activities have
been assigned to methoxy, hydroxyl, α,β-unsaturated car-
bonyl, or diketone groups present in curcumin (Liang
et al. 2009). Several modified curcumins have been synthe-
sized and studied for better efficacy. One of the major me-
tabolites of curcumin is THC, which lacks the α,β-
unsaturated carbonyl moiety and is white in color. The
change of chemical structure may modify its functionality
and efficacy.
Although the cause of OA is unknown, it is highly
associated with inflammation. Various enzymes and
cytokines such as COX-2, 5-lipooxygenase, TNF-α, IL-1,
IL-6, IL-8, IL-17, IL-21, IL-23, and monocyte chemotac-
tic protein-1 (MCP-1) are associated with inflammation
(Jain et al. 2009). Among these, TNF-α is a major medi-
ator of inflammation which activates caspase-mediated
apoptosis, nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB), activator protein-1, c-Jun N-
terminal kinase, p38, and mitogen-activated protein kinase
signaling and leads to cell apoptosis. The production of
TNF-α from macrophages is activated by various stimuli
such as LPS and MIA (Leys et al. 2013; Orita et al. 2011).
Curcumin suppresses the gene expression of TNF-α, IL6,
and IL8 induced by UVB and LPS, thereby suppressing in-
flammation (Liang et al. 2009). Pae et al. (2008) has
Fig. 6 The mRNA expression of matrix metalloproteinases and pro-inflammatory cytokines in the articular cartilage at 21 days after intra-articular
injection of monoiodoacetate (MIA). Ovariectomized (OVX) rats were provided with a 45 % fat diet containing (1) 0.4 % curcumin, (2) 0.4 %
tetrahydrocurcumin (THC), (3) 30 μg/kg body weight 17β-estradiol + 0.4 % dextrin (positive control), (4) 0.4 % dextrin (control), or (5) 0.4 % dextrin
(normal control for osteoarthritis). At the beginning of the fifth week, an articular injection of monoiodoacetate into the right knee was performed
on all OVX groups except the normal-control group and the assigned diets were provided for an additional 3 weeks. Rats in the normal-control
group had an articular injection of saline in the right knee. The mRNA expressions of MMP3 and MMP13 involved in collage degradation (a) and
cytokines (TNF-α, IL1β, and IL6) that result in inflammation (b) were measured by real-time PCR. Each bar and error bar represents the mean ± SD
(n = 6). (a, b, c) The bars with different letters were significantly different among groups by Tukey’s test at P < 0.05
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is located at the α,β-unsaturated carbonyl moiety of cur-
cumin and that THC is therefore less effective for anti-
inflammatory activity. However, it has been reported that
curcumin and THC have similar inhibitory effects on
TNF-α production, and NF-κB activation in LPS-
administered mice (Nishida et al. 2010). However, the pro-
duction of reactive oxygen species are suppressed better
by THC than by curcumin (Nishida et al. 2010). Some
studies have even shown that THC provides superior pro-
tection against inflammation and apoptosis in animal
studies (Song et al. 2015; Wu et al. 2014). Therefore, THC
is reported to have some different activities and efficacies
with different molecular targets in comparison to curcu-
min (Aggarwal et al. 2015). However, THC has not been
previously studied for relieving OA. The present study
found that curcumin and THC had a similar efficacy for
preventing the exacerbation of OA by decreasing the ex-
pression of cytokines such as TNF-α, IL1β, and IL6 in the
articular cartilage.
MMP family proteins are involved in the breakdown of
the extracellular matrix in normal physiological processes,
such as embryonic development, reproduction, and tissue
remodeling. These proteins include interstitial collage-
nases 1 and 3 (MMP1 and MMP13, respectively), gelati-
nases A and B (MMP2 and MMP9, respectively), and
stromelysin-1 (MMP3) (Clutterbuck et al. 2009). MMPs
exert these activities regulating the release of growth fac-
tors and cytokines. These MMPs are involved in the deg-
radation of proteoglycans and non-helical regions of
collagens to develop OA. Excess MMP activity is associ-
ated with extracellular matrix destruction in various in-
flammatory conditions including OA (Clutterbuck et al.
2009). Previous studies have demonstrated that themRNA and protein of MMP2, 3, 9, and 13 are detected in
the tibial plateau cartilage, but only mRNA levels of
MMP1 are detected (Gepstein et al. 2002). Thus, MMP3
and MMP13 are involved in collagen degradation, leading
to the development of OA (Henrotin et al. 2010; Moon
et al. 2013; van den Berg 2011). The present study showed
that curcumin and THC decreased the expression of
MMP3 and MMP13 in the articular cartilage, which may
have prevented the breakdown of collagen in the knee.
Their mRNA expression and protein levels are tightly reg-
ulated by transcriptional, translational, and posttransla-
tional stages (Gepstein et al. 2002; van den Berg 2011). It
is better to measure protein levels and activities, but due
to the limitation of the samples, only mRNA levels were
determined. MMP expression is associated with the cata-
bolic actions of pro-inflammatory cytokines such as TNF-
α, IL1β, and IL6 in the articular cartilage of animals and
humans, and their expression is increased by stimulating
NF-κB signaling and impairing TGF-β signaling. Previous
studies have demonstrated that curcumin decreased
MMP13 in chondrocytes derived from rabbit and sup-
pressed the NF-ĸB activation via the inhibition of IĸBα
phosphorylation (Henrotin et al. 2010; Yang et al. 2013).
Thus, not only curcumin but also THC suppressed the
degradation of articular cartilage and MMP3 and MMP13
expressions.
OA and diabetes commonly co-exist, and clinical stud-
ies have suggested that diabetes may augment the devel-
opment and severity of OA (King and Rosenthal 2015).
The progression of OA is also associated with glucose
homeostasis. It is well known that serum glucose levels
are positively associated with advanced glycation end
products (AGEs) and diabetes increases AGE in the cir-
culation and tissues (Cohen 2013). In addition, AGE in
Fig. 7 The histopathological features of osteoarthritic lesions in the knee joints of rats at 21 days after intra-articular injection of monoiodoacetate
(MIA). Ovariectomized (OVX) rats were provided with a 45 % fat diet containing (1) 0.4 % curcumin, (2) 0.4 % tetrahydrocurcumin (THC), (3)
30 μg/kg body weight 17β-estradiol + 0.4 % dextrin (positive control), (4) 0.4 % dextrin (control), or (5) 0.4 % dextrin (normal control for
osteoarthritis). At the beginning of the fifth week, an articular injection of monoiodoacetate into the right knee was performed on all OVX groups
except the normal-control group and the assigned diets were provided for an additional 3 weeks. Rats in the normal-control group had an
articular injection of saline in the right knee. The depth and extent of cartilage damage and the quantification of the damage (a) and histology
(b) were determined in hematoxylin-eosin-stained, paraffin-embedded knee joint sections from MIA-injected rats (magnifying power ×10). In
addition, the depth and extent of cartilage damage and quantification of the cartilage damage (c) and histology (d) in the MIA-injected knees
were evaluated in safranin-O fast green-stained, paraffin-embedded knee joint sections from the osteoarthritic rats (magnifying power ×10). Each
bar and error bar represents the mean ± SD (n = 5). (a, b, c, d, e) Values of the bars with different superscripts were significantly different among
groups by the Tukey test at P < 0.05
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et al. 2001; Yan and Li 2013). Increased AGE in the ar-
ticular cartilage is one of the possible mediators of OA.
Intracellular AGE accumulation in chondrocytes is asso-
ciated with the occurrence and progression of OA
through ER stress (Yamabe et al. 2013). Thus, although
we did not determine AGEs in this study, hypergly-
cemia- and glucose-derived AGEs could contribute to
the development of OA (Yan and Li 2013) and should
be studied in the future. In the present study, interest-
ingly, THC, but not curcumin, enhanced glucose toler-
ance after glucose challenge in the present study. This
indicated that serum glucose levels may be lower aftermeals with THC treatment and it may decrease AGE in
the articular cartilage. This may delay the initiation and
progression of OA in the long term. Therefore, THC
might have better effects for long-term treatment of OA
than curcumin. Therefore, the duration of the study is
one limitation of the study since long-term effects may
not have been revealed in this study. Other limitations
include the use of animal models since OVX does not
fully mimic menopause and MIA injections do not fully
mimic the etiology of osteoarthritis. However, both are
useful and well-established models. Finally, rodents may
not metabolize bioactive compounds such as curcumin
and THC in the same ways as do humans. Therefore,
Park et al. Genes & Nutrition  (2016) 11:2 Page 12 of 13the results of this study should be confirmed in human
clinical trials.
Conclusions
Curcumin and THC lessened OA symptoms and pain-
related behaviors in estrogen-deficient rats fed a high-fat
diet. THC exhibited better changes in MIA-injected
knee morphology than curcumin possibly by reducing
MMP3 and MMP13 expressions. In addition, THC, but
not curcumin, improved glucose tolerance, which might
indirectly delay the long-term progression of osteoarth-
ritis. THC and curcumin are potential new candidates
for treating postmenopausal symptoms and osteoarth-
ritis in humans, and THC appears to have some advan-
tages over curcumin for long-term treatment.
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